Oh great
@venkmurthy And look here: https://t.co/DwQr82AtQ9 New MMWR study on bivalent booster VE, modest at best -- yet coupled with a blanket recommendation for all.
RT @mahesh_shenai: https://t.co/mVcJrbKQzQ Quite literally in this MMWR, they report only 22-28% absolute VE in 50-65yos... ...then later…
RT @mahesh_shenai: https://t.co/mVcJrbKQzQ Quite literally in this MMWR, they report only 22-28% absolute VE in 50-65yos... ...then later…
👀Bivalent #boosters provided significant additional protection against symptomatic #SARSCoV2 infection in persons who had previously received 2, 3, or 4 monovalent vaccine doses. 💉💉🦠📉🙏🏻https://t.co/F2RqFi15zD
https://t.co/mVcJrbKQzQ Quite literally in this MMWR, they report only 22-28% absolute VE in 50-65yos... ...then later conclude this is "significant additional protection" and recommend ALL PERSONS should get bivalent boosters after 2 mos. from last dose
RT @mahesh_shenai: https://t.co/mVcJrbKQzQ Quick takes from new MMWR study on bivalent efficacy (after a monovalent series): 1. Modest <…
RT @mahesh_shenai: https://t.co/mVcJrbKQzQ Quick takes from new MMWR study on bivalent efficacy (after a monovalent series): 1. Modest <…
RT @DocJeffD: "...bivalent mRNA booster formulations, bivalent boosters provided significant additional protection against symptomatic SARS…
RT @bhrenton: New today: First efficacy estimates against symptomatic COVID-19 in bivalent boosted people: - Bivalent boosters increased p…
New today: First efficacy estimates against symptomatic COVID-19 in bivalent boosted people: - Bivalent boosters increased protection regardless of number of previous doses received - Proterction higher with more time since most recent monovalent dose htt
RT @W7VOA: Here's the study Dr. Fauci just referenced during his likely final appearance in the @WhiteHouse briefing room. https://t.co/bWG…
https://t.co/mVcJrbKQzQ Quick takes from new MMWR study on bivalent efficacy (after a monovalent series): 1. Modest <50% efficacy overall, vs. unvaxxed 2. Trend to 🔽efficacy w/ more prior monovalent boosts 3. 🔽efficacy in older age group Not impress
@DamonLinker I believe that the latest data is that it still reduces infection by around 50 percent. So I don't think that it's wrong to say that it protects the community. We've said similar thinga about the flu vaccine which has similar infecti protecti
https://t.co/mVcJrbKQzQ New MMWR study reporting VE in bivalent boosters. Modest <50% efficacy at best, and worse in older ages. More to analysis come . . . https://t.co/1jJXI19CC7
RT @Alexander_Tin: New in @CDCMMWR: our first look at effectiveness of updated bivalent boosters relative to 2 monovalent shots against s…
New data on fouth dose (bivalent) seem to be not so good https://t.co/1xNEz48FCZ https://t.co/46ufLqSeVp
RT @SuffolkCoHealth: In this study, bivalent mRNA boosters provided significant protection against symptomatic SARS-CoV-2 infection in pers…
RT @ArielCohen37: New CDC data shows the updated COVID-19 booster shots is about 50% more effective at preventing symptomatic infection com…
New data from CDC on effectiveness of bivalent (BA.4/5) mRNA Covid vaccines. Efficacy against symptomatic infection is ~30% relative to people who had the last of their two or more doses of the original 2-3 months earlier https://t.co/0CCgG5ulJy
RT @Alexander_Tin: New in @CDCMMWR: our first look at effectiveness of updated bivalent boosters relative to 2 monovalent shots against s…
RT @Alexander_Tin: New in @CDCMMWR: our first look at effectiveness of updated bivalent boosters relative to 2 monovalent shots against s…
RT @W7VOA: Here's the study Dr. Fauci just referenced during his likely final appearance in the @WhiteHouse briefing room. https://t.co/bWG…
RT @DoctorTro: The media arm of Pfizer is advertising another retrospective review https://t.co/HeSlZQcnfS
RT @W7VOA: Here's the study Dr. Fauci just referenced during his likely final appearance in the @WhiteHouse briefing room. https://t.co/bWG…
@RNAiAnalyst that chart is cut and pasted from CDC's report https://t.co/cQXqqIiazP
Real world Effectiveness study and Quote: "In this study of vaccine effectiveness of the U.S.-authorized bivalent mRNA booster formulations, bivalent boosters provided significant additional protection against symptomatic SARS-CoV-2 infection..." https://
shoutout all boosted bois we out here
RT @ArielCohen37: New CDC data shows the updated COVID-19 booster shots is about 50% more effective at preventing symptomatic infection com…
RT @ArielCohen37: New CDC data shows the updated COVID-19 booster shots is about 50% more effective at preventing symptomatic infection com…
RT @Alexander_Tin: New in @CDCMMWR: our first look at effectiveness of updated bivalent boosters relative to 2 monovalent shots against s…
RT @W7VOA: Here's the study Dr. Fauci just referenced during his likely final appearance in the @WhiteHouse briefing room. https://t.co/bWG…
RT @ArielCohen37: New CDC data shows the updated COVID-19 booster shots is about 50% more effective at preventing symptomatic infection com…
RT @cmsub: (New CDC data showing an updated bivalent booster provides additional protection against symptomatic infection compared w/ 2 dos…
RT @DocJeffD: "...bivalent mRNA booster formulations, bivalent boosters provided significant additional protection against symptomatic SARS…
RT @Alexander_Tin: New in @CDCMMWR: our first look at effectiveness of updated bivalent boosters relative to 2 monovalent shots against s…
RT @Alexander_Tin: New in @CDCMMWR: our first look at effectiveness of updated bivalent boosters relative to 2 monovalent shots against s…
RT @Alexander_Tin: New in @CDCMMWR: our first look at effectiveness of updated bivalent boosters relative to 2 monovalent shots against s…
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022. MMWR Morb Mortal Wkly Rep. ePub: 22 November 2022. DOI: https://t.co/gTPZPyEizv
(New CDC data showing an updated bivalent booster provides additional protection against symptomatic infection compared w/ 2 doses of the original vaccine) https://t.co/bnnVxKHizi
"...bivalent mRNA booster formulations, bivalent boosters provided significant additional protection against symptomatic SARS-CoV-2 infection in persons who had previously received 2, 3, or 4 monovalent vaccine doses." Get your updated booster. https://t
"Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection..." #COVID19 CDC https://t.co/VPKThOLAOz
RT @ArielCohen37: New CDC data shows the updated COVID-19 booster shots is about 50% more effective at preventing symptomatic infection com…
RT @ArielCohen37: New CDC data shows the updated COVID-19 booster shots is about 50% more effective at preventing symptomatic infection com…
It’s good to see clinical efficacy numbers on the bivalent boosters. A few points—better to wait 8 months or so post last vaccination in low risk individuals; this is early efficacy so unclear how long will last; how durable against the BA4/5 descendants?
RT @Alexander_Tin: New in @CDCMMWR: our first look at effectiveness of updated bivalent boosters relative to 2 monovalent shots against s…
Go get the new shots!
RT @ArielCohen37: New CDC data shows the updated COVID-19 booster shots is about 50% more effective at preventing symptomatic infection com…
Here's the study Dr. Fauci just referenced during his likely final appearance in the @WhiteHouse briefing room. https://t.co/bWGiEzPGid
In this study, bivalent mRNA boosters provided significant protection against symptomatic SARS-CoV-2 infection in persons who received 2, 3, or 4 monovalent vaccine doses. The benefit increased with time since receipt of the most recent monovalent dose. ht
New CDC data shows the updated COVID-19 booster shots is about 50% more effective at preventing symptomatic infection compared 2 doses of the original shot. https://t.co/6zZ7boukks
EARLY RELEASE: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing … https://t.co/daeT17A5ZW https://t.co/f9rp8QX9jc
Ok another not very useful study but better than nothing. The bivalent BA5 booster had produced *some* protection against BA5 symptomatic infection in people with waned prior vax. Summary: Elderly might benefit during the winter wave. 💝
The media arm of Pfizer is advertising another retrospective review https://t.co/HeSlZQcnfS
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 Early Release / November 22, 2022 / 71 via #MMWR Center…https://t.co/pWhHHvHsnG